Intelligent Medicine Acquisition Corp.
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand20.70M Perf Week-0.10%
Market Cap267.04M Forward P/E- EPS next Y- Insider Trans- Shs Float20.70M Perf Month1.87%
Income- PEG- EPS next Q- Inst Own16.58% Short Float / Ratio0.00% / 0.01 Perf Quarter2.68%
Sales- P/S- EPS this Y- Inst Trans- Short Interest0.00M Perf Half Y2.35%
Book/sh0.00 P/B10330.00 EPS next Y- ROA- Target Price- Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.94 - 10.58 Perf YTD0.78%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-2.34% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low3.98% ATR0.05
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)55.68 Volatility0.31% 0.23%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.17 Prev Close10.34
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume4.72K Price10.33
Recom- SMA200.15% SMA501.18% SMA2002.08% Volume5,506 Change-0.10%
Apr-05-22 05:16PM
Dec-23-21 04:05PM
Nov-09-21 09:18PM
Nov-04-21 06:23PM
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.